본문 바로가기 주 메뉴 바로가기 페이지 하단 바로가기

Research
and
Development

We will be born again as the pharmaceutical professional company through continuous R&D.

NCE

Code Indication Development Stage Route of Administration
SA001 Dry eye syndrome Clinical Phase II Oral
Sjogren syndrome Clinical Phase I Oral
SJ-3366 HIV Preclinical / Clinical Oral / Topical
SJ-3902 Cancer Preclinical Oral
SJP1601 Cancer Preclinical Oral
SJP1602 Cancer Biological Testing Oral
SJP1604
(APTA-16)
Cancer Preclinical Injection
SJP1610 Cancer Biological Testing Oral
SJP1701
SJP1702
Alzheimer's disease
Diabetes
Biological Testing Oral
SJP1801 Alzheimer's disease Biological Testing Oral

IMD

Code Indication Development Stage Route of Administration
SJP002 Dry eye syndrome Clinical Phase II Topical
SJP004 HIV, HBV Clinical Oral
SJP003 Platelet aggregation Biological Testing Oral
SJP005 Hormones Biological Testing Injection